נאופרו 4 מ"ג / 24 שעות

Land: Israel

Sprog: hebraisk

Kilde: Ministry of Health

Aktiv bestanddel:

ROTIGOTINE 4 MG / 24 HOUR

Tilgængelig fra:

CTS LTD

ATC-kode:

N04BC09

Lægemiddelform:

PATCHES

Indgivelsesvej:

TRANSDERMAL

Fremstillet af:

UCB MANUFACTURING IRELAND LTD

Terapeutisk gruppe:

ROTIGOTINE

Terapeutiske indikationer:

Neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through the late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on-off" fluctuations).

Autorisation dato:

2012-09-01